| For: | Dajani AI, Popovic B. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World J Clin Cases 2020; 8(21): 5235-5249 [PMID: 33269259 DOI: 10.12998/wjcc.v8.i21.5235] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i21/5235.htm |
| Number | Citing Articles |
| 1 |
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology 2021; 1(1) doi: 10.31146/1682-8658-ecg-185-1-4-52
|
| 2 |
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, Branko Popovic. Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines. Pharmacological Reports 2024; 76(3) doi: 10.1007/s43440-024-00595-4
|
| 3 |
Daria A. Teplyuk, Aliya A. Kaisina, Shabnam I. Ibragimova, Afina A. Bestavashvili, Irina O. Tinkova, Evgeniia Iu. Pashkova, Jamilya A. Kaibullayeva, Alexander V. Nersesov, Chavdar S. Pavlov. Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review. Consilium Medicum 2023; 25(5) doi: 10.26442/20751753.2023.5.202272
|
| 4 |
Asad Izziddin Dajani, Branko Popovic, Caroline Amand, Sabine Tong, Kirill Maximovich Starostin, Victor Goncharuk. MANPOWER study: Real-world post-hoc analysis assessing essential phospholipids for non-alcoholic fatty liver disease from the Russian registry. World Journal of Hepatology 2025; 17(6): 103217 doi: 10.4254/wjh.v17.i6.103217
Abstract(384) |
Core Tip(400) |
Full Article(HTML)(2419)
|
Full Article (PDF)-2352K(169)
|
Full Article with Cover (PDF)-2582K(125)
|
Full Article (XML)-119K(84)
|
Audio-1043K(46)
|
Peer-Review Report-242K(83)
|
Answering Reviewers-141K(107)
|
Supplementary Material-96K(88)
|
Times Cited (1)
|
Total Visits (3288)
|
Open
|
| 5 |
Inês Domingues, Hafsa Yagoubi, Wunan Zhang, Valentina Marotti, Espoir K. Kambale, Katlijn Vints, Malgorzata Alicja Sliwinska, Isabelle A. Leclercq, Ana Beloqui. Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease. Drug Delivery and Translational Research 2024; 14(10) doi: 10.1007/s13346-024-01576-z
|
| 6 |
Yi Pan, Feng Xue, Shanshan Wang, Bihui Zhong, Yutao Zhan, Qi Wang, Youqing Xu, Huiying Rao, Yuqiang Mi, Yuemin Nan, Xiaoyuan Xu, Branko Popovic, Xiaoqing Li, Bruno Scarpellini, Sabine Tong, Lai Wei. A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1610083
|
| 7 |
VIKTOR TOMCHUK, ANDRII POTOTSKYI, VIKTORIIA GRYSHCHENKO, STANISLAV VESELSKYI, YEVDOKIIA RESHETNIK. CORRECTION OF TRIACYLGLYCEROLS AND FREE FATTY ACIDS IN RAT BILE IN EXPERIMENTAL HEPATIC STEATOSIS. Ukrainian journal of veterinary sciences 2022; 13(2) doi: 10.31548/ujvs.13(2).2022.53-62
|
| 8 |
E. V. Biryukova. Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research. Meditsinskiy sovet = Medical Council 2024; (6) doi: 10.21518/ms2024-159
|
| 9 |
Mădălina Iuliana Mușat, Ana-Maria Ifrim-Predoi, Smaranda Ioana Mitran, Eugen Osiac, Bogdan Cătălin. The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage. International Journal of Molecular Sciences 2025; 26(8) doi: 10.3390/ijms26083558
|
| 10 |
Ch.S. Pavlov, T.A. Turankova, D.A. Teplyuk, A.V. Mudrova, Yu.P. Uspenskiy, S.N. Mekhtiev, I.G. Nikitin, A.O. Bueverov, M.F. Osipenko, A.A. Poromov. Opportunities of combination therapy for chronic liver diseases: results of the multicenter PROMETHEUS study. Russian Journal of Evidence-Based Gastroenterology 2025; 14(3) doi: 10.17116/dokgastro20251403156
|
| 11 |
Ekaterina Demicheva, Vladislav Dordiuk, Fernando Polanco Espino, Konstantin Ushenin, Saied Aboushanab, Vadim Shevyrin, Aleksey Buhler, Elena Mukhlynina, Olga Solovyova, Irina Danilova, Elena Kovaleva. Advances in Mass Spectrometry-Based Blood Metabolomics Profiling for Non-Cancer Diseases: A Comprehensive Review. Metabolites 2024; 14(1) doi: 10.3390/metabo14010054
|
| 12 |
О. В. Ткачова, М. В. Савохіна, О. Ю. Кошова. Оксидативний стрес як мішень гепатопротекторної фармакотерапії при токсичних і лікарсько-індукованих ураженнях печінки. Likarska sprava 2026; (1) doi: 10.31640/LS-2026-1-16
|
| 13 |
I. A. Bulatova, A. A. Yusupova. Comorbidity Structure, Metabolic Status and Treatment Options in Outpatients with Non-alcoholic Fatty Liver Disease and Normal Body Weight. Ural Medical Journal 2026; 25(3) doi: 10.52420/umj.25.3.34
|
| 14 |
Ludovico Abenavoli, Giuseppe La Torre, Natasa Milic. Comment on Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687. Nutrients 2023; 15(13) doi: 10.3390/nu15132907
|
| 15 |
Dominik Wupperfeld, Gert Fricker, Béatrice Bois De Fer, Larissa Frank, Annika Wehrle, Branko Popovic. Essential phospholipids decrease apoptosis and increase membrane transport in human hepatocyte cell lines. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01698-8
|
| 16 |
S. V. Okovityi, M. V. Maevskaya, V. A. Prikhodko. Essential phospholipids in the treatment of metabolic dysfunction-associated steatotic liver disease: From molecular mechanisms to clinical efficacy (a literature review). Meditsinskiy sovet = Medical Council 2026; (8) doi: 10.21518/ms2026-216
|
| 17 |
Marek Hartleb, Agnieszka Mastalerz-Migas, Piotr Kowalski, Bogusław Okopień, Branko Popovic, Katarzyna Proga, Beata Cywińska-Durczak. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. European Journal of Gastroenterology & Hepatology 2022; 34(4) doi: 10.1097/MEG.0000000000002288
|
| 18 |
A. P. Kazmirchuk, G. V. Osyodlo, V. I. Trykhlib, Yu. O. Yarmoliuk, S. P. Snizhynskyi, V. V. Kokhanivskyi, K. V. Savichan, Yu. Ya. Kotyk. Ефективність схем лікування реактивного гепатиту у поранених вогнепальною зброєю . Ukrainian Journal of Military Medicine 2025; 6(1) doi: 10.46847/ujmm.2025.1(6)-087
|
| 19 |
Vladimir T. Ivashkin, Marina V. Maevskaya, Elena N. Shirokova, Igor V. Maev, Alexey A. Samsonov, Evgeniy I. Sas, Liudmila K. Palgova, Kirill Starostin. Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies. Drugs - Real World Outcomes 2021; 8(3) doi: 10.1007/s40801-021-00250-x
|
| 20 |
Stanislav Veselskyi, Andrii Pototskyi, Viktor Tomchuk, Viktoriia Gryshchenko, Yevdokiia Reshetnik. Phospholipid composition of bile and blood in rats under correction of experimental fatty hepatosis. Ukrainian journal of veterinary sciences 2023; 14(3) doi: 10.31548/veterinary3.2023.25
|
| 21 |
Tung Hoang, Van Mai Truong, Tho Thi Anh Tran, Bao Le Thai Tran, Ngoc Hong Cao. Association between metabolites and hepatocellular carcinoma: findings from a two-sample Mendelian randomization study. Journal of Liver Cancer 2025; 25(2) doi: 10.17998/jlc.2025.08.26
|
| 22 |
Ali Madian. Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action. World Journal of Hepatology 2025; 17(11): 110725 doi: 10.4254/wjh.v17.i11.110725
|
| 23 |
Asad Izziddin Dajani, Adnan Abuhammour. Agents for the treatment of fatty liver disease: focus on essential phospholipids. Drugs & Therapy Perspectives 2021; 37(6) doi: 10.1007/s40267-021-00838-x
|
| 24 |
V. A. Prikhodko, S. V. Okovityi. Pharmacodynamic and pharmacokinetic aspects of combined use of glycyrrhizinic acid. Experimental and Clinical Gastroenterology 2023; (8) doi: 10.31146/1682-8658-ecg-216-8-141-150
|
| 25 |
M. S. Danilova, M. L. Maksimov, R. A. Bontsevich, A. V. Kalmykov. Modern approaches to the treatment of non-communicable liver diseases, the possibility of using drugs with hepatoprotective activity. Terapevt (General Physician) 2025; (10) doi: 10.33920/MED-12-2510-07
|
| 26 |
S. V. Bulgakova, Yu. A. Dolgikh, L. A. Sharonova, O. V. Kosareva, E. V. Treneva, P. Ya. Merzlova, D. P. Kurmayev. Modern aspects of therapy of metabolic associated liver disease in patients with type 2 diabetes mellitus. Meditsinskiy sovet = Medical Council 2024; (16) doi: 10.21518/ms2024-414
|
| 27 |
Inês Domingues, Isabelle A. Leclercq, Ana Beloqui. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery. Journal of Controlled Release 2023; 363 doi: 10.1016/j.jconrel.2023.09.040
|
| 28 |
V. A. Gryshchenko, O. О. Danchenko, S. A. Tkachuk, T. I. Fotina, V. V. Zazharskyi, V. V. Brygadyrenko. Lipid composition of blood plasma and epithelium of the jejunal mucosa in calves with dyspepsia and its correction . Regulatory Mechanisms in Biosystems 2023; 14(2) doi: 10.15421/022347
|
| 29 |
L. B. Lazebnik, S. V. Turkina, E. V. Golovanova. Targeted use of hepatoprotectors for the treatment of various stages of non-alcoholic fatty liver disease (fatty degeneration of the liver according to ICD 10) and associated comorbid conditions; tables for medical use. Experimental and Clinical Gastroenterology 2024; (10) doi: 10.31146/1682-8658-ecg-230-10-11-35
|
| 30 |
Ki M. Mak, Aditya C. Shekhar. Soybean polyenylphosphatidylcholine (PPC) is beneficial in liver and extrahepatic tissue injury: An update in experimental research. The Anatomical Record 2024; 307(6) doi: 10.1002/ar.25333
|
| 31 |
D. A. Teplyuk, M. Ch. Semenistaya, S. M. Sorokoletov, L. B. Lazebnik, Ch. S. Pavlov. Nonalcoholic liver disease: review with a focus on risks of progression. Experimental and Clinical Gastroenterology 2021; (8) doi: 10.31146/1682-8658-ecg-192-8-167-174
|
| 32 |
Sergey V. Okovityi, Karina L. Raikhelson, Veronika A. Prikhodko. Combined hepatoprotective pharmacotherapy for liver disease. Experimental and Clinical Gastroenterology 2022; (7) doi: 10.31146/1682-8658-ecg-203-7-5-20
|
| 33 |
Akshatha N. Srinivas, Diwakar Suresh, Prajna Anirvan, Manju Moorthy, Gopalkrishna Ramaswamy, Suma M. Nataraj, Prasanna Kumar Santhekadur, Deepak Suvarna, Shivaram P. Singh, Divya P. Kumar. Hepatic loss of AATF attenuates MASH by suppressing AKT–mTORC1 signaling and reprogramming lipid metabolism. Molecular Medicine 2026; 32(1) doi: 10.1186/s10020-025-01417-w
|
| 34 |
Dan-Ionuț Gheonea, Cristina Tocia, Victor-Mihai Sacerdoțianu, Alexandra-Georgiana Bocioagă, Irina-Paula Doica, Nicolae Cătălin Manea, Adina Turcu-Știolică, Carmen-Nicoleta Oancea, Eugen Dumitru. Therapeutic Efficacy of Silymarin, Vitamin E, and Essential Phospholipid Combination Therapy on Hepatic Steatosis, Fibrosis, and Metabolic Parameters in MASLD Patients: A Prospective Clinical Study. International Journal of Molecular Sciences 2025; 26(12) doi: 10.3390/ijms26125427
|
| 35 |
Iryna Klymas, Liudmyla Khimion. Aminotransferases activity on additional therapy in rheumatoid arthritis patients with liver disease.. Journal of Clinical Medicine of Kazakhstan 2024; 21(2) doi: 10.23950/jcmk/14398
|
| 36 |
Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, Konstantinos Arvanitakis, Georgios Germanidis, Helen Gika. Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115965
|
| 37 |
V. T. Ivashkin, O. M. Drapkina, M. V. Maevskaya, K. L. Raikhelson, S. V. Okovityi, M. S. Zharkova, V. R. Grechishnikova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, P. O. Bogomolov, V. V. Breder, E. V. Vinnitskaya, N. I. Geyvandova, E. V. Golovanova, V. B. Grinevich, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, K. B. Kodzoeva, I. V. Kozlova, K. A. Komshilova, Yu. V. Konev, N. V. Korochanskaya, Yu. V. Kotovskaya, Yu. A. Kravchuk, I. D. Loranskaya, I. V. Maev, A. I. Martynov, S. N. Mekhtiev, E. E. Mishina, M. Yu. Nadinskaia, I. G. Nikitin, M. F. Osipenko, O. D. Ostroumova, Ch. S. Pavlov, N. V. Pogosova, V. G. Radchenko, G. E. Roytberg, R. G. Saifutdinov, A. A. Samsonov, P. V. Seliverstov, S. I. Sitkin, L. V. Tarasova, A. I. Tarzimanova, O. N. Tkacheva, E. I. Tkachenko, E. A. Troshina, S. V. Turkina, Yu. P. Uspenskiy, Yu. A. Fominykh, O. V. Khlynova, Yu. V. Tsyganova, M. Sh. Shamkhalova, O. O. Sharkhun, M. V. Shestakova. Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2025; 35(1) doi: 10.22416/1382-4376-2025-35-1-94-152
|
| 38 |
Yulong Zhao, Xutao Li, Guihong Luo, Ryosuke Matsuoka, Yimeng Zhao, Qingqing Jiang, Long Zhang, Wenzheng Shi, Xichang Wang, Mingyu Yin. Multi-step infrared macro-fingerprint features and lipid metabolism in HepG2 cells: Intervention of different sourced phospholipids. Applied Food Research 2025; 5(2) doi: 10.1016/j.afres.2025.101125
|
| 39 |
Tatiana Y. Demidova, Fatima O. Ushanova. Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review. Terapevticheskii arkhiv 2023; 95(10) doi: 10.26442/00403660.2023.10.202435
|
| 40 |
D. Osipova, K. Kokoreva, L. Lazebnik, E. Golovanova, Ch. Pavlov, A. Dukhanin, S. Orlova, K. Starostin. Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.797923
|
| 41 |
Hui Peng, Jiangyuan Li, Huiting Xu, Xian Wang, Leya He, Naomi McCauley, Ke K. Zhang, Linglin Xie. Offspring NAFLD liver phospholipid profiles are differentially programmed by maternal high-fat diet and maternal one carbon supplement. The Journal of Nutritional Biochemistry 2023; 111 doi: 10.1016/j.jnutbio.2022.109187
|